Tuberculosis

Showing NaN - NaN of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)

Not yet recruiting
  • Tuberculosis
  • HIV Infections
  • VPM1002 Vaccine
  • +2 more
  • Johannesburg, Gauteng, South Africa
  • +8 more
Sep 14, 2022

Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Linezolid 600 mg
  • +7 more
  • Gaborone, South-East District, Botswana
  • +15 more
Jul 19, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Tuberculosis, HIV Trial in Haiti, India, South Africa (Bedaquiline)

Recruiting
  • Tuberculosis
  • HIV Infections
  • Port-au-Prince, Haiti
  • +4 more
Jun 15, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))

Completed
  • HIV Infections
  • Tuberculosis
  • Levonorgestrel (LNG)
  • Chicago, Illinois
  • +17 more
Dec 22, 2021

HIV, Tuberculosis Trial in Worldwide (Isoniazid (INH), Placebo for isoniazid (INH))

Completed
  • HIV Infections
  • Tuberculosis
  • Isoniazid (INH)
  • Placebo for isoniazid (INH)
  • Gaborone, Botswana
  • +12 more
Nov 3, 2021

Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))

Completed
  • Tuberculosis
  • HIV Infections
  • Rifapentine (RPT)
  • +2 more
  • La Jolla, California
  • +44 more
Nov 2, 2021

Tuberculosis, Pulmonary Tuberculosis Trial in Johannesburg (Pravastatin, Rifafour, Vitamin B6)

Recruiting
  • Tuberculosis
  • Pulmonary Tuberculosis
  • Johannesburg, Gauteng, South Africa
    PHRU Non-Network CRS
Oct 29, 2021

HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)

Completed
  • HIV Infections
  • Tuberculosis
  • Efavirenz (EFV)
  • Rifampin-containing anti-TB therapy
  • Pune, Maharashtra, India
  • +6 more
Oct 28, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

Recruiting
  • Tuberculosis, Pulmonary
  • +4 more
  • Johannesburg, South Africa
  • +2 more
Oct 4, 2021

Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

Completed
  • Tuberculosis
  • San Francisco, California
  • +32 more
Sep 1, 2021

TB-CAPT MTB/XDR Study

Recruiting
  • Tuberculosis
  • +2 more
  • Xpert MTB/XDR
  • Cape Town, South Africa
  • +1 more
May 17, 2021

Tuberculosis, Hiv Trial in Johannesburg, Soshanguve (Household contact tracing)

Recruiting
  • Tuberculosis
  • Hiv
  • Household contact tracing
  • Johannesburg, South Africa
  • +1 more
Feb 10, 2021

Tuberculosis, Drug-resistant Tuberculosis Trial in Johannesburg (Contacts, Index)

Completed
  • Tuberculosis
  • Drug-resistant Tuberculosis
  • Contacts
  • Index
  • Johannesburg, South Africa
  • +1 more
Jan 7, 2021

Tuberculosis Trial in Bellville 7530, Mowbray, Johannesburg (H56:IC31, Placebo)

Completed
  • Tuberculosis
  • H56:IC31
  • Placebo
  • Bellville 7530, Cape Town, South Africa
  • +2 more
Oct 28, 2019

Evaluation of Centralised TB Assay Solutions

Unknown status
  • Tuberculosis
  • Drug-resistant Tuberculosis
    • Tbilisi, Georgia
    • +5 more
    Oct 30, 2019

    Tuberculosis, HIV Trial in Johannesburg (rifapentine + isoniazid, Isoniazid)

    Completed
    • Tuberculosis
    • HIV
    • Johannesburg, Gauteng, South Africa
      The Aurum Institute NPC
    Oct 29, 2019

    HIV, Tuberculosis, Diabetes Trial in Johannesburg (Minimum package of interventions to improve ART adherence)

    Completed
    • HIV
    • +3 more
    • Minimum package of interventions to improve ART adherence
    • Johannesburg, South Africa
      Johannesburg Site
    Jul 29, 2019

    Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

    Completed
    • Tuberculosis
    • Tembisa, Gauteng, South Africa
    • +9 more
    May 28, 2019

    HIV-1 Infection, Tuberculosis Trial in Worldwide (Depot medroxyprogesterone acetate)

    Completed
    • HIV-1 Infection
    • Tuberculosis
    • Depot medroxyprogesterone acetate
    • Gaborone, Botswana
    • +4 more
    Jun 13, 2019

    Influenza, HIV, Tuberculosis Trial in Johannesburg (Trivalent Inactivated Influenza Vaccine)

    Completed
    • Influenza
    • +2 more
    • Trivalent Inactivated Influenza Vaccine
    • Johannesburg, Gauteng, South Africa
      Respiratory and Meningeal Pathogens research unit
    Sep 3, 2018

    Tuberculosis Trial in Cape Town, Johannesburg (VPM1002, BCG, VPM1002(Hyg+))

    Completed
    • Tuberculosis
    • VPM1002
    • +2 more
    • Cape Town, South Africa
    • +3 more
    Apr 17, 2018

    Tuberculosis Trial in Johannesburg, Cape Town, Worcester (AERAS-404, Placebo)

    Completed
    • Tuberculosis
    • AERAS-404
    • Placebo
    • Johannesburg, Guateng, South Africa
    • +3 more
    Apr 6, 2018